List of Rebetol drug patents

Rebetol is owned by Schering.

Rebetol contains Ribavirin.

Rebetol has a total of 2 drug patents out of which 0 drug patents have expired.

Rebetol was authorised for market use on 29 July, 2003.

Rebetol is available in solution;oral dosage forms.

The generics of Rebetol are possible to be released after 05 October, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6790837 SCHERING Ribavirin syrup formulations
Apr, 2023

(2 months from now)

US6790837

(Pediatric)

SCHERING Ribavirin syrup formulations
Oct, 2023

(8 months from now)

Drugs and Companies using RIBAVIRIN ingredient

Market Authorisation Date: 29 July, 2003

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic